Document and Entity Information
Document and Entity Information | Jan. 05, 2021 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jan. 5, 2021 |
Entity Registrant Name | AEGLEA BIOTHERAPEUTICS, INC. |
Entity Central Index Key | 0001636282 |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | true |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-37722 |
Entity Tax Identification Number | 46-4312787 |
Entity Address, Address Line One | 805 Las Cimas Parkway |
Entity Address, Address Line Two | Suite 100 |
Entity Address, City or Town | Austin |
Entity Address, State or Province | TX |
Entity Address, Postal Zip Code | 78746 |
City Area Code | 512 |
Local Phone Number | 942-2935 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.0001 Par Value Per Share |
Trading Symbol | AGLE |
Security Exchange Name | NASDAQ |